logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11 Age at first use distributions and primary drug distributions — EU summary of clients entering treatment, 2010 or most recent year available

Part (viii) All inpatient clients, primary drug distribution by age at first use (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Age knownAge not known
Opiates20.150.769.769.063.760.146.634.9143992131
Cocaine3.06.77.17.37.88.68.25.11753494
Stimulants16.618.89.46.67.24.66.71.73983272
Hypnotics and sedatives3.92.83.36.38.416.926.143.51265367
Hallucinogens0.10.30.30.40.30.40.70.08091
Volatile substances2.71.30.60.40.80.40.40.734230
Cannabis 45.215.85.43.52.81.84.91.04549933
Other substances 8.43.74.36.69.07.36.313.01462792
Total462912621580724941173549268292278335110
 

Notes:

Countries reporting data: BE, BG, CZ, DK, DE, IE, EL, FR, CY, LU,HU, NL, AT, PL, RO, SK, FI, SE, UK, HR, TR.

The number of treatment clients in each country is listed in Table TDI-7.

See also Table 109 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page.

Source:

Reitox national reports 2011 — Table TDI — outpatient treatment centres.

Page last updated: Monday, 09 July 2012